Literature DB >> 18290603

Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase.

Albert C Pierce1, Marc Jacobs, Cameron Stuver-Moody.   

Abstract

To supplement the hits from a high throughput screen, docking was performed against Pim-1 kinase. Glide docking was augmented with a filter to require traditional or aromatic CH..O hydrogen bonds to the kinase hinge. Four diverse actives, of 96 molecules assayed, had K(i) values between 0.091 and 4.5 microM. This gives a 14-fold enrichment over the earlier HTS run, and the two crystal structures solved confirmed the binding modes predicted by docking.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290603     DOI: 10.1021/jm701248t

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

1.  Chemical space sampling by different scoring functions and crystal structures.

Authors:  Natasja Brooijmans; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2010-04-18       Impact factor: 3.686

2.  Biased retrieval of chemical series in receptor-based virtual screening.

Authors:  Natasja Brooijmans; Jason B Cross; Christine Humblet
Journal:  J Comput Aided Mol Des       Date:  2010-10-30       Impact factor: 3.686

Review 3.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

Review 4.  Docking Screens for Novel Ligands Conferring New Biology.

Authors:  John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2016-03-15       Impact factor: 7.446

5.  A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer.

Authors:  Jong-Eun Kim; Joe Eun Son; Hyein Jeong; Dong Joon Kim; Sang Kwon Seo; Eunjung Lee; Tae Gyu Lim; Jong Rhan Kim; Hanyong Chen; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Res       Date:  2015-05-06       Impact factor: 12.701

6.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.

Authors:  G Madhavi Sastry; Matvey Adzhigirey; Tyler Day; Ramakrishna Annabhimoju; Woody Sherman
Journal:  J Comput Aided Mol Des       Date:  2013-04-12       Impact factor: 3.686

7.  Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor.

Authors:  Mustapha Haddach; Jerome Michaux; Michael K Schwaebe; Fabrice Pierre; Sean E O'Brien; Cosmin Borsan; Joe Tran; Nicholas Raffaele; Suchitra Ravula; Denis Drygin; Adam Siddiqui-Jain; Levan Darjania; Ryan Stansfield; Chris Proffitt; Diwata Macalino; Nicole Streiner; Joshua Bliesath; May Omori; Jeffrey P Whitten; Kenna Anderes; William G Rice; David M Ryckman
Journal:  ACS Med Chem Lett       Date:  2011-12-27       Impact factor: 4.345

Review 8.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

Review 9.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

10.  Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.

Authors:  Zuping Xia; Christian Knaak; Jian Ma; Zanna M Beharry; Campbell McInnes; Wenxue Wang; Andrew S Kraft; Charles D Smith
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.